Decheng Capital as of June 30, 2026
Portfolio Holdings for Decheng Capital
Decheng Capital holds 14 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 61.9 | $453M | 6.4M | 71.05 | |
| Nuvation Bio (NUVB) | 20.1 | $147M | 26M | 5.68 | |
| Aardvark Therapeutics (AARD) | 3.1 | $23M | 3.9M | 5.76 | |
| Aclaris Therapeutics (ACRS) | 2.9 | $21M | 4.0M | 5.29 | |
| Upstream Bio (UPB) | 2.6 | $19M | 2.7M | 6.92 | |
| Arcus Biosciences Incorporated (RCUS) | 2.0 | $14M | 465k | 30.83 | |
| Equillium (EQ) | 1.9 | $14M | 4.4M | 3.20 | |
| Revolution Medicines (RVMD) | 1.3 | $9.9M | 53k | 187.28 | |
| Lyell Immunopharma | 1.3 | $9.7M | 692k | 14.05 | |
| BeyondSpring SHS (BYSI) | 0.9 | $6.7M | 3.8M | 1.75 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.9 | $6.4M | 1.3M | 4.85 | |
| Newamsterdam Pharma Co Nv (NAMS) | 0.8 | $6.0M | 177k | 33.89 | |
| Pyxis Oncology (PYXS) | 0.1 | $984k | 327k | 3.01 | |
| Tango Therapeutics (TNGX) | 0.1 | $625k | 20k | 31.26 |
